Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 31 Clinical Trials
ID/Name Source Type
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
NCT01723826 clinicaltrials.gov Clinical Trial
A Non-drug Methods Study in Participants With Alzheimer's Disease
NCT01459016 clinicaltrials.gov Clinical Trial
A Safety Study of LY2811376 Single Doses in Healthy Subjects
NCT00838084 clinicaltrials.gov Clinical Trial
A Safety Study of LY2886721 Multiple Doses in Healthy Subjects
NCT01227252 clinicaltrials.gov Clinical Trial
A Safety Study of LY2886721 Single Doses in Healthy Subjects
NCT01133405 clinicaltrials.gov Clinical Trial
A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
NCT02353598 clinicaltrials.gov Clinical Trial
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)
NCT02951598 clinicaltrials.gov Clinical Trial
A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.
NCT00765115 clinicaltrials.gov Clinical Trial
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
NCT01807026 clinicaltrials.gov Clinical Trial
A Study of LY3002813 and LY3202626 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)
NCT03367403 clinicaltrials.gov Clinical Trial